Abstract
Further chemical modification of 2-iminopiperidines fused to cyclopropane rings was performed. Optically active isomers 2 and 13 were synthesized and their biological activity was evaluated. Compound 2 exhibited greater potency and more isoform selectivity than enantiomer 13 in the iNOS inhibition assay. One of the gem-chlorines on the fused cyclopropane moiety of 2 was eliminated to produce 3, which showed reduced potency for iNOS inhibition, as well as 4 with an increased potency. The isoform selectivity of 4 was also much higher than that of 3. This was also true for the corresponding methyl derivatives 6-9. The structure-activity relationship (SAR) study and computer aided docking study of the most optimized structure 4 with human iNOS will also be reported.
MeSH terms
-
Animals
-
Biological Availability
-
Bridged Bicyclo Compounds / chemical synthesis*
-
Bridged Bicyclo Compounds / chemistry
-
Bridged Bicyclo Compounds / pharmacology*
-
Bridged Bicyclo Compounds / toxicity
-
Crystallography, X-Ray
-
Cyclopropanes / chemical synthesis
-
Cyclopropanes / chemistry
-
Cyclopropanes / pharmacology
-
Drug Design
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology*
-
Enzyme Inhibitors / toxicity
-
Humans
-
Imines / chemical synthesis*
-
Imines / chemistry
-
Imines / pharmacology*
-
Imines / toxicity
-
Inhibitory Concentration 50
-
Magnetic Resonance Spectroscopy
-
Mice
-
Mice, Inbred BALB C
-
Nitric Oxide Synthase / antagonists & inhibitors*
-
Nitric Oxide Synthase / genetics
-
Nitric Oxide Synthase Type II
-
Piperidines / chemical synthesis
-
Piperidines / chemistry
-
Piperidines / pharmacology
-
Recombinant Proteins / antagonists & inhibitors
-
Recombinant Proteins / genetics
-
Recombinant Proteins / metabolism
-
Structure-Activity Relationship
-
omega-N-Methylarginine / pharmacology
Substances
-
Bridged Bicyclo Compounds
-
Cyclopropanes
-
Enzyme Inhibitors
-
Imines
-
Piperidines
-
Recombinant Proteins
-
omega-N-Methylarginine
-
NOS2 protein, human
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse